ARA290

Chemical Information:

• Peptide Sequence: Cys‑Glu‑Glu‑Ala‑Val‑Lys‑Gln‑Glu‑Glu‑Ser‑Ser‑Leu‑Glu‑Glu‑Cys
• Length: 15 amino acids
• Molecular Formula: C₆₄H₁₁₀N₂₀O₂₄S₂
• Molecular Weight: ~1474.6 Da

Description:

ARA290 is a synthetic peptide derived from erythropoietin (EPO) with neuroprotective and anti-inflammatory properties. It is primarily researched for nerve protection, pain relief, and tissue repair without stimulating red blood cell production. Supplied as a high-purity lyophilized powder, ARA290 is intended for laboratory and preclinical studies exploring neuroprotection, immune modulation, and chronic pain mechanisms. For research use only; not approved for human or veterinary applications.

Research Applications:

• Neuroprotection Studies – Investigating mechanisms for neuronal survival and protection against injury.
• Pain Relief Research – Studying effects on neuropathic and chronic pain pathways.
• Anti-Inflammatory & Tissue Repair Studies – Exploring inflammation modulation and tissue recovery.
• Preclinical Disease Models – Testing efficacy in models of nerve injury, neurodegeneration, or chronic disorders.

Storage and Handling:

• Store at -20°C in a tightly sealed container, protected from light and moisture.
• Store at 2–8°C; avoid repeated freeze-thaw cycles to maintain peptide stability.
• Use sterile techniques when reconstituting and transferring solutions to prevent contamination.

Product Specifications:

• Appearance: Pale beige cream, aqueous formulation
• Purity: Peptides ≥ 98% (HPLC verified)
• Solubility: Pre-formulated in aqueous cream base

Compliance Notice:

ARA290 peptide is intended strictly for research and laboratory use only. It is not approved for human or veterinary use and has not been evaluated by any regulatory authority. Unauthorized use, including clinical application or self-administration, is strictly prohibited. Researchers must follow all local, national, and institutional regulations when handling this peptide.